Corporate Welfare Deluxe!
Dr. Weeks’ Comment: Let’s leave the welfare moms alone (abusing the system for $300/month) and let’s go after the BIG cheaters like these folk. Bernie […]
Corporate Welfare Deluxe! Read More »
Is Double blind placebo controlled still the best?
Dr. Weeks’ Comment: My dear friend, mentor and perpetual inspiration, Dr. Abram Hoffer, M.D. Ph.D writes thoughtfully about the limitations to the “gold standard” in
Is Double blind placebo controlled still the best? Read More »
Corrective Cancer care – summary and references
Corrective Cancer Care Posted by Brad Weeks, MD on February 1, 2011 Corrective Cancer Care Posted by Brad Weeks, MD on March 5, 2004 Corrective
Corrective Cancer care – summary and references Read More »
Haelan – multi-faceted cancer killer
Dr. Weeks Recommends: Haelan 951 – a fermented, organic, non-GMO soy product This product contains all 5 of the super foods discovered in 1991 by
Haelan – multi-faceted cancer killer Read More »
Nudging the standard of care – always risky.
Read the words of Prof. Max Wicha, M.D. Distinguished Professor of Oncology Director, University of Michigan Comprehensive Cancer Center “chemotherapy and radiation make your cancer
Nudging the standard of care – always risky. Read More »
Patient – be fully informed re chemotherapy
Dr. Weeks’ Comment: Everyone is trying her and his best to care for patient suffering with cancer. There are differences of opinion among good people
Patient – be fully informed re chemotherapy Read More »
Vitamin C kills cancer cells and spares you
Dr. Weeks’ Comment: I read as much of what Bill Sardi writes as possible. Here he summarizes the importance of vitamin C in fighting cancer.
Vitamin C kills cancer cells and spares you Read More »
Using insulin to selectively target cancer cells
Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol. 2004 Mar;53(3):220-4. Epub 2003 Dec 4 Lasalvia-Prisco E, Cucchi S,
Using insulin to selectively target cancer cells Read More »